45 phenotypes from 7 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
PrkcdM1Btlr/PrkcdM1Btlr C57BL/6J-PrkcdM1Btlr	increased susceptibility to induced colitis	J:265145
Prkcdm2Btlr/Prkcdm2Btlr C57BL/6J-Prkcdm2Btlr	enhanced humoral immune response	J:265146
	increased IgM level	J:265146
	increased NK cell number	J:265146
	increased susceptibility to induced colitis	J:265146
Prkcdtm1.1Chou/Prkcdtm1.1Chou involves: C57BL/6 * C57BL/6NTac	abnormal neutrophil physiology	J:217880
Prkcdtm1.1Khn/Prkcdtm1.1Khn B6.129P2-Prkcdtm1.1Khn	improved glucose tolerance	J:173902
	increased insulin sensitivity	J:173902
Prkcdtm1Kin/Prkcdtm1Kin involves: 129P2/OlaHsd	abnormal bone ossification	J:117333
	abnormal osteoblast differentiation	J:117333
	decreased width of hypertrophic chondrocyte zone	J:117333
Prkcdtm1Kin/Prkcdtm1Kin involves: 129P2/OlaHsd * C57BL/6	abnormal immunoglobulin level	J:143854
	abnormal lymph node germinal center morphology	J:76135
	abnormal pancreatic beta cell morphology	J:120293
	abnormal Peyer's patch germinal center morphology	J:76135
	abnormal plasma cell differentiation	J:143854
	decreased body weight	J:120293
	decreased insulin secretion	J:120293
	enlarged lymph nodes	J:76135
	enlarged spleen	J:76135
	glomerulonephritis	J:76135
	impaired glucose tolerance	J:120293
	increased acute inflammation	J:76135
	increased anti-chromatin antibody level	J:76135
	increased B cell number	J:76135
	increased B cell proliferation	J:76135, J:143854
	increased follicular B cell number	J:143854
	increased IgA level	J:76135, J:143854
	increased IgG1 level	J:76135, J:143854
	increased IgM level	J:143854
	increased interleukin-6 secretion	J:76135
	increased marginal zone B cell number	J:143854
	increased spleen germinal center number	J:76135
	increased transitional stage B cell number	J:143854
	renal glomerular immunoglobulin deposits	J:76135
Prkcdtm1Msg/Prkcdtm1Msg involves: 129X1/SvJ * C57BL/6J	abnormal neutrophil physiology	J:91377
	abnormal response to CNS ischemic injury	J:91377
	decreased neutrophil cell number	J:91377
Prkcdtm1Qxu/Prkcdtm1Qxu B6.129P2-Prkcdtm1Qxu	decreased body weight	J:173902
	decreased liver triglyceride level	J:173902
	improved glucose tolerance	J:173902
	increased insulin sensitivity	J:173902
	premature death	J:173902
Prkcdtm1Qxu/Prkcdtm1Qxu involves: 129P2/OlaHsd	abnormal cardiovascular system physiology	J:78680
	abnormal response to transplant	J:78680
	arteriosclerosis	J:78680
	vascular smooth muscle hyperplasia	J:78680
Prkcdtm1Qxu/Prkcdtm1Qxu involves: 129P2/OlaHsd * C57BL/6	enlarged lymph nodes	J:76134
	enlarged spleen	J:76134
	normal immune system phenotype	J:76134
	increased anti-nuclear antigen antibody level	J:76134
	increased B cell apoptosis	J:76134
	increased B cell number	J:76134
	increased erythrocyte cell number	J:76134
	increased IgA level	J:76134
	increased IgG1 level	J:76134
	increased IgM level	J:76134
	premature death	J:76134